Alliance Global Partners lowered shares of Viveve Medical (NASDAQ:VIVE – Get Rating) from a buy rating to a neutral rating in a report issued on Monday morning, The Fly reports.
Viveve Medical Price Performance
Shares of NASDAQ:VIVE opened at $0.10 on Monday. The company's fifty day moving average price is $0.45 and its 200-day moving average price is $0.61. The firm has a market capitalization of $1.04 million, a price-to-earnings ratio of -0.04 and a beta of 0.35. Viveve Medical has a one year low of $0.09 and a one year high of $1.24.
Get
Viveve Medical alerts:
Viveve Medical (NASDAQ:VIVE – Get Rating) last issued its quarterly earnings results on Thursday, November 10th. The company reported ($0.59) EPS for the quarter. The company had revenue of $1.68 million during the quarter. Viveve Medical had a negative return on equity of 306.23% and a negative net margin of 355.33%.
Viveve Medical Company Profile
(Get Rating)
Viveve Medical, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components.
Featured Articles
- Get a free copy of the StockNews.com research report on Viveve Medical (VIVE)
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- What Does Microsoft's Investment in ChatGBT Mean for MSFT Stock?
- Analysts Like The Fit Of Skechers USA
- Can We Trust The Rally In The S&P 500
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.
Alliance Global Partners股價下跌萬歲醫療(納斯達克:VIVE-GET評級)在週一上午發佈的一份報告中,Fly的評級從買入評級變成了中性評級。
Viveve醫療性價比
納斯達克:VIVE的股價週一開盤報0.1美元。該公司的50日移動均線價格為0.45美元,200日移動均線價格為0.61美元。該公司市值為104萬美元,本益比為-0.04,貝塔係數為0.35。Viveve Medical的一年低點為0.09美元,一年高位為1.24美元。
到達
Viveve醫療警報:
Viveve Medical(納斯達克:VIVE-GET評級)最近一次發佈季度收益報告是在11月10日(星期四)。該公司公佈了該季度每股收益(0.59美元)。該公司本季度的收入為168萬美元。Viveve Medical的淨資產回報率為負306.23%,淨利潤率為負355.33%。
Viveve醫療公司簡介
(獲取評級)
Viveve Medical,Inc.與其子公司一起設計、開發、製造和銷售用於非侵入性治療陰道內分泌鬆弛、性功能、陰道年輕化和壓力性尿失禁的醫療設備。該公司提供的Viveve系統包括射頻發生器、可重複使用的手機和治療尖端,以及冷凍劑罐和其他消耗品部件。
專題文章
- 免費獲取StockNews.com關於Viveve Medical的研究報告(VIVE)
- 諾斯羅普·格魯曼公司的拋售是一個機會嗎?
- Under Armor Stock的新任CEO是最糟糕的嗎?
- 微軟投資ChatGBT對微軟股票意味著什麼?
- 分析師喜歡斯凱奇美國公司的Fit
- 我們能相信標普500指數的漲勢嗎
接受Viveve醫學日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Viveve Medical和相關公司的最新新聞和分析師評級的每日簡要摘要。